Replay webinar

Circulating Tumor Cell Analysis: a new workflow combining ScreenCell® Technology with Stilla Crystal Digital PCR®

About Stilla Technologies :

A pioneer company in digital PCR (dPCR), Stilla provides high-precision molecular analysis solutions for applications in oncology, liquid biopsy, infectious disease research, and more. Their Crystal Digital PCR™ technology, powered by the Nio® Digital PCR system, enables absolute quantification of nucleic acids with exceptional sensitivity and reproducibility.

Follow ScreenCell® on LinkedIn